drugset / Trial / NCT04355169
A Study of Naldemedine in Participants Undergoing Surgeries That Include a Bowel Resection or Bowel Transection
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to compare the efficacy of naldemedine versus placebo and to assess its effect on the time to gastrointestinal (GI) recovery following surgeries that include bowel resection and bowel transection.
Timeline
- Start
- 2020-11-06
- Primary completion
- 2021-01-04
- Completion
- 2021-01-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naldemedine | Other / unclassified | 1.25 mg | Oral |
| Subject | Naldemedine | Other / unclassified | 2.5 mg | Oral |
| Subject | Naldemedine | Other / unclassified | 5 mg | Oral |